1. Home
  2. Analysis
  3. Pregabalin
  4. Performance-status-decreased

Pregabalin and Performance status decreased - a phase IV clinical study of FDA data

Summary:

Performance status decreased is reported as a side effect among people who take Pregabalin (pregabalin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Carboplatin, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Performance status decreased when taking Pregabalin. It is created by eHealthMe based on reports of 73,056 people who have side effects when taking Pregabalin from the FDA, and is updated regularly.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,070 Pregabalin users. Check the latest studies of Pregabalin.

What is Performance status decreased?

Performance status decreased is found to be associated with 513 drugs and 637 conditions by eHealthMe. Check the latest studies of Performance status decreased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

73,056 people reported to have side effects when taking Pregabalin.
Among them, 11 people (0.02%) have Performance status decreased.

Could Pregabalin cause Performance status decreased?

Among these 11 people:

How long have people been on Pregabalin when they have Performance status decreased? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Performance status decreased when taking Pregabalin? *

  • female: 36.36 %
  • male: 63.64 %

What is the age of people who have Performance status decreased when taking Pregabalin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 25 %
  • 50-59: 25 %
  • 60+: 50 %

What are other drugs people take besides Pregabalin? *

  1. Amlodipine: 3 people, 27.27%
  2. Carboplatin: 3 people, 27.27%
  3. Metformin: 2 people, 18.18%
  4. Pantoprazole: 2 people, 18.18%
  5. Aspirin: 2 people, 18.18%
  6. Dexamethasone: 2 people, 18.18%
  7. Diclofenac: 2 people, 18.18%
  8. Enhertu: 2 people, 18.18%
  9. Lyrica: 2 people, 18.18%
  10. Novorapid: 2 people, 18.18%

What are other side effects people have besides Performance status decreased? *

  1. Fatigue (feeling of tiredness): 5 people, 45.45%
  2. Nausea And Vomiting: 2 people, 18.18%
  3. Dyspnea (difficult or laboured breathing): 2 people, 18.18%
  4. Anaemia (lack of blood): 2 people, 18.18%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 18.18%
  6. Sleep Disorder: 2 people, 18.18%
  7. Interstitial Lung Disease: 2 people, 18.18%
  8. Catheter Site Infection (infection at the site of insertion): 2 people, 18.18%
  9. Diarrhea: 2 people, 18.18%
  10. Nausea (feeling of having an urge to vomit): 2 people, 18.18%

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 3 people, 27.27%
  2. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 18.18%
  3. High Blood Pressure: 2 people, 18.18%
  4. Breast Cancer: 2 people, 18.18%
  5. Neck Pain: 2 people, 18.18%
  6. Diabetes: 2 people, 18.18%
  7. Metastases To Central Nervous System (cancer spreads to central nervous system): 2 people, 18.18%
  8. Headache (pain in head): 2 people, 18.18%
  9. Rickets (softening of bones): 2 people, 18.18%
  10. Cancer Pain: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Pregabalin and have Performance status decreased?

- Check whether Performance status decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pregabalin:

Performance status decreased treatments and more:

How severe was Performance status decreased and when was it recovered:

Expand to all the drugs that have ingredients of pregabalin:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Performance status decreased:

Browse all the conditions that are associated with Performance status decreased:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on pregabalin (the active ingredients of Pregabalin) and Pregabalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.